Form 8-K - Current report:
SEC Accession No. 0001628280-18-002048
Filing Date
2018-02-22
Accepted
2018-02-22 16:05:34
Documents
2
Period of Report
2018-02-22
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K admsearningsreleaseq42017.htm 8-K 30363
2 EXHIBIT 99.1 adms2017q4991.htm EX-99.1 98572
  Complete submission text file 0001628280-18-002048.txt   130155
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

EIN.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36399 | Film No.: 18632539
SIC: 2834 Pharmaceutical Preparations